Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


Needham Analyst Recommends Isis Pharmaceuticals

Source: http://ceoblogger.wordpress.com/2008/08/09/needham-analyst-recommends-isis-pharmaceuticals/
 Posted on Saturday, August 9th, 2008 | In Current Market News, Market Commentary, Stocks to Watch
Contributed by: CEO Blogger (http://ceoblogger.wordpress.com) -

NEEDHAM Analyst Recomends Isis Pharmaceuticals

a. Needham analyst Mark Monane says ISIS reported second quarter results (highlighted by solid cash position of $537 million)

b. reviewed progress of mipomersen and updated partner progress on other drug trials,  and updated expected events for second half of 2008 and early 2009.

c. Monane thinks upcoming milestones in these programs represent upside opportunity for the stock. In the long-term, he sees substantial commercial potential in IBIS antisense platform.

d. $22 target price on the stock.

Track Needham’s analysts picks at:

http://trackthepros.com/categories.php?category_id=448

Last 5 posts by CEO Blogger
About CEO Blogger (http://ceoblogger.wordpress.com)
CEOBlogger helps investors evaluate companies.

DISCLAIMER

The commentary on this blog is not meant to be taken as an investment advice. The author is not a registered investment adviser. There is no substitute for your own due diligence. Please be aware that investing is inherently a risky business and if you chose to follow any of the advice on this site, then you are accepting the risks associated with that investment.

The Author may have also taken positions in the stocks that are being discussed and the author may change his position at any time without warning.

With this in mind, I hope you do enjoy the posts and the views presented here and hopefully it generates some profitable ideas for your investments.

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.